期刊文献+

血清-腹水白蛋白梯度对门脉高压、食管-胃底静脉曲张破裂出血的意义 被引量:2

下载PDF
导出
摘要 目的探讨血清-腹水白蛋白梯度(SAAG)与门脉高压的关系,评价SAAG对预测门脉高压性食管-胃底静脉曲张破裂出血的价值。方法 62例肝硬化腹水患者SAAG均≥11g/L,属于门脉高压性腹水。通过胃镜检查分为食管-胃底静脉曲张破裂出血组(26例)和非出血组(36例),测定两组SAAG值和门静脉内径进行比较。结果食管-胃底静脉曲张破裂出血组SAAG(22.24±7.18)g/L、门静脉内径(1.4±0.2)g/L,均高于非出血组(16.27±6.06)g/L、(1.0±0.2)g/L,两组比较差异有显著性(P<0.05)。SAAG与食管-胃底静脉曲张(EV)、破裂出血情况分析,SAAG水平越高,EV和出血发生率越高,不同梯度水平比较,差异有显著性(P<0.05)。结论 SAAG与门脉高压密切相关,且对预测门脉高压性食管-胃底静脉曲张破裂出血有一定临床价值。
出处 《中国临床医生杂志》 2014年第10期35-36,共2页 Chinese Journal For Clinicians
  • 相关文献

参考文献6

二级参考文献31

  • 1《中国常见恶性肿瘤诊治规范》原发性肝癌诊断标准[J].中华肝胆外科杂志,1998,4(2):103-103. 被引量:14
  • 2肖绍树.食管静脉曲张破裂出血危险的预测[J].新医学,1996,27(4):222-223. 被引量:22
  • 3王吉耀.门脉高压国际会议报道.中华消化杂志,1995,15:352-352.
  • 4Runyon BA, Montano AA, Akriviadis EA, et al. The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites.Ann Intern Med,1992,117:215-220.
  • 5Villamil FG, Sorroche PB, Aziz HF, et al. Ascitic fluid alpha 1-antitrypsin. Dig Dis Sci, 1990,35:1105-1109.
  • 6Runyon BA. Care of patients with ascites. N Engl J Med,1994,330:337-341.
  • 7Runyon BA.Ascites. In: Schiff L, Schiff E, eds. Disease of the Liver. Philadelphia: JB Lippincott. 1993.
  • 8Hoefs JC. Serum protein concentration and portal pressure determine the ascitic fluid protein concentration in patients with chronic liver disease. J Lab Clin Med,1983,102:260-273.
  • 9Schepis F,Camma C,Niceforo D,et al.Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection ?Hepatology,2001,33:333-338.
  • 10D' Amico G, Pagliaro L, Pietrosi G, et al. Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patients [ J ]. Cochrane Database Syst Rev, 2010,17 ( 3 ) :CD002233.

共引文献97

同被引文献30

  • 1王友春,马建党,范银忠.血清-腹水白蛋白梯度与食管静脉曲张关系的临床研究[J].临床肝胆病杂志,2006,22(1):45-46. 被引量:7
  • 2张莉,张澍田,于中麟,王伟,徐宝宏,张福奎.血清-腹水白蛋白梯度与食管-胃底静脉曲张破裂出血的关系[J].临床内科杂志,2007,24(2):92-93. 被引量:12
  • 3D'AMICO G, de FRANCHIS R. Upper digestive bleeding in cirrhosis. Post -therapeutic outcome and prognostic indica- tors[J]. Hepatology, 2003, 38(3},- 599-612.
  • 4GARCIA -TSAO G, SANYAL A J, GRACE ND, et al. Preven- tion and management of gastroesophageal varices and variceal hemorrhage in cirrhosis [ J ]. Hepatology, 2007, 46 (3} 922 -938.
  • 5von ELM E, ALTMAN DG, EGGER M, et al. Strengthening the reporting of observational studies in epidemiology (StroBE} statement, guidelines for reporting observational studies[ J ]. BMJ, 2007, 335 ( 7624 ) 806 -808.
  • 6WALLACE BC, SCHMID CH, LAU J, et al. Meta -Analyst. software for meta -analysis of binary, continuous and diag-nostic data[J]. BMC Med Res Methodol, 2009, 9(1 ) : 80.
  • 7HOEFS JC. Serum protein concentration and portal pressure determine the ascitic fluid protein concentration in patients with chronic liver disease[J]. J Lab Clin Med, 1983, 102 (2) ; 260 -273.
  • 8PA-FFERSQN SW, STARLING EH. Qn the mechanical factors which determine the output of the ventricles[ J ]. J Physiol, 1914, 48= 357 -379.
  • 9RUNYON BA. Management of adult patients with ascites due to cirrhosis= an update [J]. Hepatology, 2009, 49(6)= 2087 - 2107.
  • 10GROSZMANN R J, GARCIA -TSAO G, BOSCH J, et al. Be- ta- blockers to prevent gastroesophageal varices in patients with cirrhosis[J]. N EnglJ Med, 2005, 353(21): 2254- 2261.

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部